This week’s Derms on Drugs 6-pack moves past theory and into real decisions—what actually helps you pick the rightdrug for the patient in front of you. From gene expression profiling that predicts JAK vs Th2 response to the growing concern around dupilumab and CTCL, and more, this episode separates signal from noise—and gives you a few things you won’t forget (looking at you, abscopal effect).
AI Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Pick Your Own Treatment Adventure
Regenerative Derm: Baloney or Breakthrough?
Derms on Drugs takes on the AAD late breaking research, Part 2
Derms on Drugs takes on the AAD late breaking research, Part 1
Free AI-powered recaps of Derms on Drugs and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.